TinyGemsBreaks Archive - Page 5 of 124

ThursdayApr 10, 2025 9:10 am

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Appoints Oncology Expert Dr. Guy Travis Clifton as Chief Medical Officer

Calidi Biotherapeutics (NYSE American: CLDI) has named Dr. Guy Travis Clifton as Chief Medical Officer, Consultant and Advisor. The appointment comes as Calidi advances clinical development of CLD-201, a virotherapy for solid tumors, following a recently filed Investigational New Drug application. Dr. Clifton brings over 17 years of oncology and clinical trial expertise, including leadership roles at Parthenon Therapeutics and service as a surgical oncologist in the U.S. Army. His extensive experience in immunotherapy is expected to bolster Calidi’s efforts in developing stem cell-based and enveloped virus cancer therapies. To view the full press release, visit: https://ibn.fm/lsJgC About Calidi Biotherapeutics…

ThursdayApr 10, 2025 8:40 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Partners With Enpower Greentech to Produce Solid-State Batteries in California

Mullen Automotive (NASDAQ: MULN) has signed a Partnership and Supply Agreement with Enpower Greentech Inc. to manufacture and deliver SWIFT Series semi solid-state batteries ("SSB") for use in commercial vehicles and various industrial applications. Production will take place at Mullen’s Battery Center in Fullerton, California, with full-scale manufacturing targeted for early 2026. The collaboration supports Mullen’s strategy to domestically produce high-performance battery solutions while mitigating tariff impacts and supply chain risks. To view the full press release, visit https://ibn.fm/eh8NN About Mullen Automotive Inc. Mullen Automotive is a Southern California-based automotive company building the next generation of commercial electric vehicles (“EVs”)…

WednesdayApr 09, 2025 9:59 am

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) Subsidiary Wins UK Government Contract for Satellite Communication Devices

NextPlat (NASDAQ: NXPL, NXPLW) announced that its subsidiary, Global Telesat Communications Ltd, has secured its first contract with a central UK government department to supply Iridium Push-To-Talk (PTT) satellite communication devices and recurring airtime services. The devices, designed for secure and reliable global communication, will support government staff engaged in policy development and coordination. Initial shipments are scheduled for the second quarter and will not be impacted by recent U.S. tariffs. To view the full press release, visit https://ibn.fm/DJmcP About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology…

WednesdayApr 09, 2025 9:20 am

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Appoints Data Center Veteran as Advisor for Market Expansion

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) has retained Jonathan Martone of Martone Advisors LLC to guide its planned expansion into the data center industry. Martone brings over 25 years of experience in telecommunications and data center development, including site selection, power grid strategy, and infrastructure planning. SolarBank first announced its strategic interest in the data center sector in November 2024 and is actively evaluating potential opportunities to support growing demand from AI-driven computing needs. To view the full press release, visit https://ibn.fm/OECeT About SolarBank Corporation SolarBank Corporation is an independent renewable and clean energy project developer…

TuesdayApr 08, 2025 1:04 pm

TinyGemsBreaks – Authentic Holdings Inc. (AHRO) Announces Strategic Collaboration to Expand Global Reach of iDreamCTV

Authentic Holdings (OTC: AHRO) today announced a partnership between its subsidiary, Maybacks Global Entertainment, and LIME X, a global developer of TV streaming services on Android, iOS, Smart TV, Android TV and Web platforms. “Our partnership with LIME X is another great step forward, allowing our TV streaming app, iDreamCTV, and its 42 channels to be seen by a very large global audience,” said Authentic Holdings President and Chairman Chris H Giordano. “LIME X has had over 100,000,000+ downloads of their platform. Our content will now be seen by another huge global audience and allow us to capture significant revenue…

MondayApr 07, 2025 3:34 pm

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Driving Clean Energy Innovation Through Multiple Projects

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) is a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and the U.S. The company recently announced a partnership with Viridi, the industry leader in fail-safe battery energy storage systems (“BESS”), to develop a combined 3.06 megawatt (“MW”) direct current ground-mounted solar power project and a 1.2 megawatt-hour (“MWh”) BESS, in Buffalo, New York. “This initiative aims to transform a closed landfill into a productive asset that generates clean energy for the local community. Once operational,…

ThursdayApr 03, 2025 9:30 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Highlights U.S. Assembly and Tariff Exempt Status for EV Lineup

Mullen Automotive (NASDAQ: MULN) announced that its Mullen and Bollinger commercial electric vehicles are fully assembled in the United States and exempt from recently announced tariffs on vehicles and components. With 67% and 71% of components sourced domestically for Mullen and Bollinger respectively, the company emphasizes its commitment to U.S. manufacturing and supply chain stability. Mullen’s lineup includes the Mullen ONE and Mullen THREE, while Bollinger offers the B4 chassis cab, which began deliveries in October 2024. To view the full press release, visit https://ibn.fm/KnGDK About Mullen Automotive Inc. Mullen Automotive is a Southern California-based automotive company building the next…

TuesdayApr 01, 2025 11:09 am

TinyGemsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Acquires Skytech to Expand AI Robotics in Hospitality Sector

Nightfood Holdings (OTCQB: NGTF), an innovator in hospitality automation, has acquired Skytech Automated Solutions, Inc., a leader in AI-driven service technologies for hotels. This strategic move follows Nightfood’s recent acquisition of Carryout Supplies and enhances its Robotics-as-a-Service (RaaS) offerings. Skytech’s Laundry Helper robot, already in use at multiple hotel properties, will now be integrated into Nightfood’s broader automation platform to improve operational efficiency and guest experience. The combined capabilities are expected to boost market reach, recurring revenue, and operational scalability. To view the full press release, visit https://ibn.fm/Mtbgi About Nightfood Holdings Inc. Nightfood is a forward-thinking holding company dedicated to…

TuesdayApr 01, 2025 10:00 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position

CNS Pharmaceuticals (NASDAQ: CNSP) a biopharmaceutical company targeting brain and CNS cancers, reported a full-year 2024 net loss of $14.9 million, down from $18.9 million in 2023, due to reduced R&D spending. Despite Berubicin missing its primary endpoint in a glioblastoma multiforme (GBM) trial, the drug demonstrated safety and comparable efficacy, guiding future analysis. The company is shifting focus to TPI 287, a candidate with orphan drug designation and prior clinical data. With $6.5 million in cash at year-end and an additional $9.9 million raised post-period, CNS expects funding to last through Q1 2026. To view the full press release,…

TuesdayApr 01, 2025 9:40 am

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $3.9 Million Offering to Advance Immunotherapy Programs

Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company developing targeted immunotherapies, closed its previously announced registered direct offering and concurrent private placement with a single institutional investor, raising approximately $3.9 million in gross proceeds. The offering included 3,325,000 shares of common stock and pre-funded warrants for 2,728,000 shares, along with Series G warrants for 6,053,000 shares. Proceeds will support working capital and advance Calidi’s clinical and preclinical cancer therapy programs. To view the full press release, visit: https://ibn.fm/wgwu3 About Calidi Biotherapeutics Calidi Biotherapeutics specializes in proprietary technology that empowers the immune system to combat cancer. The company’s novel stem…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks